Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novanta (NOVT) Cash & Equivalents: 2009-2025

Historic Cash & Equivalents for Novanta (NOVT) over the last 17 years, with Sep 2025 value amounting to $89.2 million.

  • Novanta's Cash & Equivalents fell 3.74% to $89.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $89.2 million, marking a year-over-year decrease of 3.74%. This contributed to the annual value of $114.0 million for FY2024, which is 8.51% up from last year.
  • Latest data reveals that Novanta reported Cash & Equivalents of $89.2 million as of Q3 2025, which was down 18.83% from $109.9 million recorded in Q2 2025.
  • Novanta's Cash & Equivalents' 5-year high stood at $133.9 million during Q3 2021, with a 5-year trough of $76.0 million in Q3 2023.
  • Its 3-year average for Cash & Equivalents is $96.3 million, with a median of $93.5 million in 2024.
  • Per our database at Business Quant, Novanta's Cash & Equivalents soared by 54.08% in 2021 and then declined by 24.93% in 2022.
  • Quarterly analysis of 5 years shows Novanta's Cash & Equivalents stood at $117.4 million in 2021, then declined by 14.73% to $100.1 million in 2022, then climbed by 4.94% to $105.1 million in 2023, then increased by 8.51% to $114.0 million in 2024, then fell by 3.74% to $89.2 million in 2025.
  • Its Cash & Equivalents was $89.2 million in Q3 2025, compared to $109.9 million in Q2 2025 and $106.0 million in Q1 2025.